Informed Surgery

Explore surgeries / General and other surgery

Your guide to TAVR

TAVR, explained

Transcatheter aortic valve replacement (TAVR, also called TAVI) replaces a narrowed aortic valve through a thin tube, usually inserted in a blood vessel in the groin, instead of through open-heart surgery. In the US it's now done more often than surgical valve replacement. This guide explains aortic stenosis, how TAVR compares with surgery at different ages and risk levels, how long the new valves last, and what recovery is like. It's written for patients and for the adult children who often help them decide.

Where are you right now?

I'm considering surgery

Alternatives, likely benefits, risks, the main choices and what to ask.

My surgery is scheduled

Getting ready: home setup, rides, help, costs and your appointment questions.

I'm recovering

What recovery usually looks like and planning everyday life. Your care team's discharge instructions tell you when to call them.

At a glance

What the procedure does
Replaces a narrowed aortic valve with a new tissue valve delivered on a catheter, usually through the groin, without opening the chest.
Why people consider it
Severe aortic stenosis causing symptoms such as breathlessness, chest discomfort or fainting.[1][3]
The main choices
TAVR or open surgery, which depends mostly on age, expected lifespan and anatomy, and for people without symptoms, now or later.[3][13]
What recovery involves
Usually home within a couple of days, with more energy over the following weeks.[14]
What to ask your heart team
Why they recommend TAVR or surgery for you, how long the valve may last, and your pacemaker risk.

The short version

  • Aortic stenosis is a narrowing of the heart's main outflow valve, mostly from calcium buildup with age. It affects about 2% of people over 65.[1]
  • In randomized trials, TAVR has done as well as or better than open surgery in the first years across high, intermediate and low surgical risk.[5][6][7][8][9][12]
  • Age and expected lifespan matter most. US guidelines generally favor surgery under 65, TAVR over 80, and a shared decision in between.[3]
  • The big open question is how long TAVR valves last in younger people. Low-risk trials have followed patients for about five years so far.[10][11]
  • People more often need a permanent pacemaker after TAVR than after surgery.[11][14]

What aortic stenosis is

The aortic valve opens with each heartbeat to let blood out of the heart into the body. In aortic stenosis, calcium builds up and the valve can't open fully, so the heart has to work harder. It mostly affects older people, and happens sooner in people born with a two-leaflet (bicuspid) valve.[1]

Most people don't have symptoms until the narrowing is advanced. It's often first found when a doctor hears a heart murmur.[1] Symptoms can include chest discomfort that gets worse with activity, shortness of breath, tiring easily, dizziness or fainting.[1]

When to replace the valve

For severe aortic stenosis that causes symptoms, valve replacement is recommended.[3] Medicines can ease symptoms but can't open the valve. In the first TAVR trial, in people too frail for surgery, about 31% died within a year after TAVR compared with about 51% with standard care.[5]

If you have no symptoms yet

Guidelines have traditionally recommended regular checkups for severe stenosis without symptoms. In the 2025 EARLY TAVR trial of 901 people without symptoms, early TAVR lowered the combined rate of death, stroke or unplanned heart hospitalization (27% versus 45%) compared with monitoring. Most of the difference was fewer hospitalizations, and 87% of the monitored group needed a valve replacement within a median of about four years.[13]

TAVR or open-heart surgery?

In surgical aortic valve replacement (SAVR), the surgeon opens the chest, stops the heart briefly using a heart-lung machine, removes the old valve and sews in a new one. The new valve can be mechanical, which lasts longer but needs lifelong blood thinners, or biological (tissue), which doesn't need lifelong blood thinners but may need replacing.[2] TAVR valves are tissue valves.

The research in detail: What the trials found
  • Intermediate risk: two large trials found death or disabling stroke at two years was similar with TAVR and surgery.[6][7]
  • Low risk: in PARTNER 3 (average age 73), the combined rate of death, stroke or rehospitalization at one year was 8.5% with TAVR versus 15.1% with surgery.[8] At five years the difference was smaller and no longer statistically significant (22.8% versus 27.2%).[10] In the Evolut Low Risk trial, death or disabling stroke at two years was 5.3% versus 6.7%.[9]
  • Everyday practice: the German DEDICATE trial of 1,414 people with low or intermediate risk found death or stroke at one year was 5.4% with TAVR versus 10.0% with surgery.[12]

Age is the deciding factor for many people

The 2020 US guideline recommends choosing based on age, expected lifespan, the valve's anatomy and patient preference. In general, it favors surgery for people under 65 or with a life expectancy over 20 years, TAVR (through the groin) for people over 80 or with less than 10 years of life expectancy, and a shared decision between 65 and 80.[3]

Medicare requires that a heart team, including a cardiac surgeon and an interventional cardiologist who have each examined you, evaluate whether surgery, TAVR or other treatment fits you best.[4]

How long do the valves last?

This is the most important unknown for younger, healthier patients. In the Nordic NOTION trial of lower-risk patients, structural wear of the valve at six years was less common with TAVR than surgery (4.8% versus 24.0%), while actual valve failure was low and similar.[16]

The research in detail

In a Japanese registry of older, higher-risk patients (average age 84), severe valve wear reached 3.0% and valve failure 10.8% at 10 years.[17] Fewer than 1 in 7 were alive at 10 years, which shows how hard it is to study durability in older patients.

If a tissue valve wears out, a second valve can often be placed inside it, through a catheter or with surgery. Ask your team what a future replacement would look like for you.

What happens during TAVR

Most TAVR procedures go through an artery in the groin. In US registry data from 2019, about 95% used this route, the typical hospital stay was 2 days, and 90% of people went straight home.[14] Many centers use light sedation rather than general anesthesia.

The new valve is folded onto a catheter, threaded up to the heart, and expanded inside the old valve, pushing it aside. Valves are either balloon-expandable or self-expanding.[8][9]

Some centers use a filter device to catch debris during the procedure. In a trial of 3,000 people, it didn't significantly reduce strokes.[15]

Recovery

  1. Days 1 to 2Walking within hours to a day. Most people go home within a couple of days.[14]
  2. First weekKeep the groin site clean, no heavy lifting for a while, and watch for bleeding or swelling there.
  3. Weeks 1 to 4Most people notice more energy and less breathlessness. You'll usually have an echocardiogram to check the valve and be told which blood thinner or antiplatelet medicine to take.
  4. Long termRegular heart checkups and echocardiograms. Tell dentists and doctors you have an artificial valve.

Recovery after open surgery is longer, usually several days in hospital and weeks before driving and normal activity.

Risks and complications

  • Pacemaker: TAVR can disturb the heart's electrical system. In US registry data about 11% needed a new pacemaker within 30 days.[14] In the Evolut Low Risk trial, 27% of people who had TAVR alone needed one by five years, compared with 9% after surgery.[11]
  • Stroke: in US registry data, stroke within 30 days fell to about 2.3%.[14] In the Evolut Low Risk trial, disabling stroke at 30 days was lower with TAVR than surgery (0.5% versus 1.7%).[9]
  • Bleeding or damage where the catheters went in, kidney injury, and leaks around the new valve.[2]
  • Death: 30-day death rates in US registry data dropped from 7.2% to 2.5% between 2011 and 2019 as the procedure moved to lower-risk patients.[14]

Questions to ask your heart team

  1. How severe is my aortic stenosis, and are my symptoms from the valve?

    Why we ask: Most people don't have symptoms until the narrowing is advanced, and symptoms can have other causes. What aortic stenosis is

  2. Given my age and health, why do you recommend TAVR, surgery or waiting?

    Why we ask: US guidelines generally favor surgery under 65, TAVR over 80, and a shared decision in between. TAVR or open-heart surgery?

  3. How long might my new valve last, and what happens if it wears out?

    Why we ask: Long-term durability in younger patients is the main unknown. A second valve can often be placed inside the first. How long do the valves last?

  4. Which valve type will you use, and what is my risk of needing a pacemaker with it?

    Why we ask: Pacemakers are more often needed after TAVR than after surgery, so ask about your own risk. Risks and complications

  5. Can it be done through the groin, and with sedation or general anesthesia?

    Why we ask: About 95% of US TAVRs go through the groin. What happens during TAVR

  6. How many TAVRs does your center do each year, and what are your outcomes?

    Why we ask: Outcomes have improved as centers gained experience. Risks and complications

  7. What blood thinners will I need afterward, and for how long?

    Why we ask: You'll usually be told which blood thinner or antiplatelet medicine to take after the procedure. Recovery

  8. If I have no symptoms, what are the pros and cons of treating now versus waiting?

    Why we ask: In a 2025 trial, early TAVR lowered death, stroke or heart hospitalization compared with monitoring. When to replace the valve

Print this page or save it to your phone, and write down the answers during your visit.

Understanding your valve options

The companies that make the implants and devices used in this surgery, compared side by side with FDA records and sources, plus recent research and FDA news explained for patients.

Your valve optionsRecent news

Insurance and costs

What to expect to pay: a published Medicare reference price for this surgery, how deductibles and coinsurance work, protections against surprise bills, and the costs people forget.

Insurance and costs

Recovery supplies

We list recovery supplies at every budget, from gel ice wraps to cold therapy machines, with what to look for in each.

  • Keeping track of medicines
  • Walking
  • Groin site care
  • Tracking how you feel

See recovery supplies

Sources

  1. MedlinePlus (US National Library of Medicine). Aortic stenosis. https://medlineplus.gov/ency/article/000178.htm
  2. National Heart, Lung, and Blood Institute. Heart valve diseases: treatment. https://www.nhlbi.nih.gov/health/heart-valve-diseases/treatment
  3. Otto CM, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease. Circulation. 2021;143:e72-e227. https://doi.org/10.1161/CIR.0000000000000923
  4. Centers for Medicare & Medicaid Services. National Coverage Determination 20.32: Transcatheter aortic valve replacement (TAVR). https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=355
  5. Leon MB, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607. https://doi.org/10.1056/NEJMoa1008232
  6. Leon MB, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609-20. https://doi.org/10.1056/NEJMoa1514616
  7. Reardon MJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321-31. https://doi.org/10.1056/NEJMoa1700456
  8. Mack MJ, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695-705. https://doi.org/10.1056/NEJMoa1814052
  9. Popma JJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706-15. https://doi.org/10.1056/NEJMoa1816885
  10. Mack MJ, et al. Transcatheter aortic-valve replacement in low-risk patients at five years. N Engl J Med. 2023;389:1949-60. https://doi.org/10.1056/NEJMoa2307447
  11. Ramlawi B, et al. Isolated transcatheter and surgical aortic valve replacement in the Evolut Low-Risk trial: 5-year comparative outcomes. Ann Thorac Surg. 2026;122:57-66. https://doi.org/10.1016/j.athoracsur.2026.03.070
  12. Blankenberg S, et al. Transcatheter or surgical treatment of aortic-valve stenosis. N Engl J Med. 2024;390:1572-83. https://doi.org/10.1056/NEJMoa2400685
  13. Généreux P, et al. Transcatheter aortic-valve replacement for asymptomatic severe aortic stenosis. N Engl J Med. 2025;392:217-27. https://doi.org/10.1056/NEJMoa2405880
  14. Carroll JD, et al. STS-ACC TVT Registry of transcatheter aortic valve replacement. J Am Coll Cardiol. 2020;76:2492-516. https://doi.org/10.1016/j.jacc.2020.09.595
  15. Kapadia SR, et al. Cerebral embolic protection during transcatheter aortic-valve replacement. N Engl J Med. 2022;387:1253-63. https://doi.org/10.1056/NEJMoa2204961
  16. Søndergaard L, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019;73:546-53. https://doi.org/10.1016/j.jacc.2018.10.083
  17. Ikuta A, et al. Ten-year clinical outcomes and valve durability after transcatheter aortic valve implantation with balloon-expandable valves. JACC Asia. 2026;6:1917-28. https://doi.org/10.1016/j.jacasi.2026.02.003

Spot an error? Tell us and we'll check it and fix it.

Get an email when it's ready

We'll send one email when is published. Nothing else unless you ask.